Background: Late-onset Alzheimer's disease (LOAD) is highly heritable. Recent research suggested that population-specific LOAD genetic risks may exist. The Mini-Mental State Examination (MMSE; a measure of global cognitive function) has been commonly used to monitor AD-related cognitive changes. MMSE raw scores have a strong ceiling effect (upper limit = 30 points). In a previous study, we demonstrated that the Tobit model utilizing ceiling information for estimation, is a superior approach compared to the linear model. In this study, we aim to employ Tobit modeling to investigate associations of single nucleotide variants (SNVs) with MMSE scores to identify population-specific genetic risks.
Method: The phenotype data were drawn from the National Alzheimer's Coordinating Center (NACC) Uniform Data Set (UDS) September 2022 data freeze. The genotype data were obtained from the Alzheimer's Disease Genetics Consortium (ADGC). Alongside self-reported race/ethnicity, we applied the principal component analysis (PCA) and uniform manifold approximation and projection (UMAP) to identify genetic-ancestry (GA) groups (Fig. 1). Within each GA group, we performed association analyses of 82 AD-related SNVs identified by a genome-wide association study (Bellenguez et al., 2022), on MMSE using mixed-effect Tobit modeling, adjusting for age at baseline, sex, education, and 2-4 PC scores. We utilized Bonferroni correction to set P = 6.10 × 10 for multiple testing.
Result: Three GA groups were included in analyses: non-Hispanic White (NHW, n = 15,112), African American (AA, n = 2,392), and Hispanic (n = 1,159). Genetic variants were associated with MMSE shown in Table 1. At baseline, in NHW, genes CR1, SORT1, PRKD3, BIN1, INPPSD, MME, UNC5CL, CD2AP, TMEM106B, SPDYE, USP6NL, MS4A4A, EED, SLC24A4, SPPL2A, MAF, PLCG2, and ABCA7 were associated with initial cognitive performance (ICP). In contrast, only BIN1 showed an association with ICP in AA, while LILRB2 was associated with ICP in Hispanics. Moreover, CR1 in NHW, NCK2 in AA, and EED in Hispanics were associated with change in MMSE scores over time.
Conclusion: Our findings underscore the importance of considering population-specific genetic variants when studying AD-related longitudinal cognitive changes. Novel genetic risks may vary across GA groups and be further revealed in future studies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.095497 | DOI Listing |
Mol Neurodegener
January 2025
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.
TREM2 is a signaling receptor expressed on microglia that has emerged as an important drug target for Alzheimer's disease and other neurodegenerative diseases. While a number of TREM2 ligands have been identified, little is known regarding the structural details of how they engage. To better understand this, we created a protein library of 28 different TREM2 variants that could be used to map interactions with various ligands using biolayer interferometry.
View Article and Find Full Text PDFFluids Barriers CNS
January 2025
Sanders-Brown Center on Aging, College of Medicine, University of Kentucky, 760 Press Ave, 124 HKRB, Lexington, KY, 40536-0679, USA.
Background: Blood-brain barrier dysfunction is one characteristic of Alzheimer's disease (AD) and is recognized as both a cause and consequence of the pathological cascade leading to cognitive decline. The goal of this study was to assess markers for barrier dysfunction in postmortem tissue samples from research participants who were either cognitively normal individuals (CNI) or diagnosed with AD at the time of autopsy and determine to what extent these markers are associated with AD neuropathologic changes (ADNC) and cognitive impairment.
Methods: We used postmortem brain tissue and plasma samples from 19 participants: 9 CNI and 10 AD dementia patients who had come to autopsy from the University of Kentucky AD Research Center (UK-ADRC) community-based cohort; all cases with dementia had confirmed severe ADNC.
Alzheimers Res Ther
January 2025
Laboratory for Clinical Neuroscience, Center for Biomedical Technology, Universidad Politécnica de Madrid, IdISSC, Crta M40, km38, Madrid, 28223, Spain.
Background: Dementia patients commonly present multiple neuropathologies, worsening cognitive function, yet structural neuroimaging signatures of dementia have not been positioned in the context of combined pathology. In this study, we implemented an MRI voxel-based approach to explore combined and independent effects of dementia pathologies on grey and white matter structural changes.
Methods: In 91 amnestic dementia patients with post-mortem brain donation, grey matter density and white matter hyperintensity (WMH) burdens were obtained from pre-mortem MRI and analyzed in relation to Alzheimer's, vascular, Lewy body, TDP-43, and hippocampal sclerosis (HS) pathologies.
J Neurochem
January 2025
The Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
Alzheimer disease is a neurodegenerative pathology-modifying mitochondrial metabolism with energy impairments where the effects of biological sex and DNA repair deficiencies are unclear. We investigated the therapeutic potential of dietary ketosis alone or with supplemental nicotinamide riboside (NR) on hippocampal intermediary metabolism and mitochondrial bioenergetics in older male and female wild-type (Wt) and 3xTgAD-DNA polymerase-β-deficient (3xTg/POLβ) (AD) mice. DNA polymerase-β is a key enzyme in DNA base excision repair (BER) of oxidative damage that may also contribute to mitochondrial DNA repair.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!